Multiplicom
Universiteit Antwerpen

Multiplicom

Biotech
Biotech
Biotech
Biotech

Acquired by Agilent Technologies.

Multiplicom was created in 2011 as a spin-off of the University of Antwerp and VIB. Multiplicom develops, manufactures and commercializes leading-edge and easy-to-use genetic test kits based on the latest molecular diagnostic technologies. Multiplicom produces molecular diagnostic kits that enable clinical laboratories to perform affordable testing for personalized medicine.

Acquired by Agilent Technologies.

No items found.

This company is aligned with the following SDGs

No items found.
THERAtRAME
Qbic III
Biotech
Biotech
Biotech
Biotech

THERAtRAME

THERAtRAME develops and positions new therapeutics targeting tRNA epitranscriptomics in cancer.

ULiège
Flindr Therapeutics
Qbic III
Biotech
Biotech
Biotech
Biotech

Flindr Therapeutics

Flindr aims to restore a patient’s impaired immune response to cancer

Universiteit Gent
Aloxy
Qbic II
Software
Software
Software
Software

Aloxy

Aloxy’s Internet of Things technology is enabling the petrochemical industry to innovate.

Universiteit Antwerpen
imec